[1] 胡亚美,江载芳,申昆玲.诸福棠实用儿科学[M].第8版.北京:人民卫生出版社,2015.981-1003.
[2] Della Valle P, Pavani G, D’Angelo A. The protein C pathway and sepsis[J]. Thromb Res, 2012, 129(3): 296-300.
[3] 唐金凤,陈先春,钟磊,等.血浆凝血因子V、VIII及蛋白C活性与下肢深静脉血栓形成的相关性[J].实验与检验医学,2015,33(1):103-105.
[4] Gale AJ, Griffin JH.Characterization of a thrombomodulin binding site on protein C and its comparison to an activated protein C binding site for factor Va[J]. Proteins, 2004, 54(3): 433-441.
[5] Tran S, Dahlback B.Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S[J]. J Thromb Haemost, 2010, 8(1): 129-136.
[6] Zeng W, Matter WF, Yan SB, et al.Effect of drotrecogin alfa (activated) on human endothelial cell permeability and Rho kinase signaling[J]. Crit Care Med, 2004, 32(5 Suppl): S302-308.
[7] Thiyagarajan M, Fernández JA, Lane SM, et al.Activated protein C promotes neovascularization and neurogenesis in post ischemic brain via protease-activated receptor 1[J]. J Neurosci, 2008, 28(48): 12788-12797.
[8] Brueckmann M, Hoffmann U, De Rossi L, et al.Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1cells and from human monocytes[J]. Cytokine, 2004, 26(3): 106-113.
[9] Roback MG, Stack AM, Thompson C, et al.Activated protein C concentrate for the treatment of meningococcal endotoxin shock in rabbits[J]. Shock, 1998, 9(2): 138-142. |
